Search Results - kathryn+wagner

2 Results Sort By:
Muscular Dystrophy Cell Lines
Unmet NeedFacioscapulohumeral muscular dystrophy (FSHD) is a complex neuromuscular disorder affecting 1 in 20,000 individuals. The disease is characterized by progressive wasting of facial, upper arm and shoulder girdle muscles. FSHD has variable age of onset, ranging from infant to late adult; and approximately one-third of patients lose the ability...
Published: 1/22/2026   |   Inventor(s): Kathryn Wagner
Keywords(s): Cell Lines, CNS and Neurological Disorders, Discovery/Research Tools, Disease Indication, Human Cell Lines, In Vitro Research Tool, Muscular Dystrophy
Category(s): Technology Classifications > Research Tools > Cell Lines, Clinical and Disease Specializations > Musculoskeletal > Muscle Atrophy
Human IPSC-Based Drug Testing Platform for Duchenne Muscular Dystrophy
Unmet NeedThe development of new drugs is a capital and time intensive process. For this reason, the development of orphan drugs for those diseases that affect a small subset of the population. One of such diseases, Duchenne’s muscular dystrophy (DMD) affects 1 in 5000 boys worldwide and has no known cure. Current drug screen platforms include animal...
Published: 1/22/2026   |   Inventor(s): Gabsang Lee, Kathryn Wagner, Congshan (Sunny) Sun
Keywords(s): Discovery/Research Tools, Disease Indication, In Vitro Research Tool, Muscular Disorders, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics
Category(s): Clinical and Disease Specializations > Rare Diseases, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Research Tools > Research Stem Cells
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum